A market leader in the evolving Cannabis market.

Incorporated in 2011, the company was founded on a commitment to the production of standardized  products. The company operates one of the first fully licensed Analytics Laboratories in Canada, accredited by Health Canada to test cannabis and derivative products for Licensed Producers (LP’s) and Access to Cannabis for Medical Purposes Regulations growers (ACMPR), as well as approved Cannabis patients. The Company is also approved as a contract extract producer, with authority to extract and produce oil, capsules and tinctures within Health Canada guidelines.

milligrams per year existing production capacity

number of clients capable of serving

sq. ft. production of processing facilities

Our Team

25 years international experience in compliance, corporate governance, audit, reporting system design and implementation, detailed analysis and forecasting. Former CFO roles in health care, hospitality and software development sectors.

With 30+ years experience in industrial production line development, design and maintenance, Cliff founded the Company in 2011. Cliff also is founder and CEO of multiple successful retail outlets in Nanaimo. He is a well-respected and trusted leader with extensive relationships and contacts in the industry. Cliff maintains relationships with regulators at both the Federal and Provincial level, and possesses a strong understanding of the regulatory and political climate in the evolving cannabis market.

LL.B, Consultant

Paul Rosen

Co-founder of PharmaCan Capital Corporation, past President and CEO, Paul currently sits on the board of iAnthis Capital Holdings, a publicly traded New York Based investment bank invested in several medical marijuana licenses across the United States. Paul is a member of the Law Society of Upper Canada, and practiced constitutional law in Canada for several years. Paul received a B.A. in Economics from Western University in 1985 and an LL.B. from the University of Toronto in 1988.


Greg Hall

Previous Director at Haywood Securities Inc.; Vice-President, Canaccord Capital Corporation; and Senior Vice-President of Leede Financial Markets Inc. He is a graduate of the Rotman School of Management, University of Toronto, SME Enterprise Board Program, and a Member of the Institute of Corporate Directors

CEO and President of Medical Marijuana Inc.

Stuart Titus

Stuart has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses. His expertise in finance was forged on Wall Street, where he worked as a bond trader for 11 years, managing a trading and underwriting department as a V.P. for CS First Boston Corp. He worked as a Physiotherapist for over 15 years, having run clinics that specialized in integrative pain management and injury rehabilitation, which treated over 40,000 patients.

Close Menu